Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8051–8100 of 18431
Shahraab Ahmad (Chairman of the Board of Directors) and Chief Executive Officer), Burt Jordan (President), Anthony Eisenberg (Chief Strategy Officer), Jason Chryssicas (Chief Financial Officer) and Ned Sizer (Chief Operating Officer) have resigned from their respective positions as officers of the Company
the following individuals will become officers of the Company: 2 Anthony (Tony) Porcheron, Chief Executive Officer
Shahraab Ahmad (Chairman of the Board of Directors) and Chief Executive Officer), Burt Jordan (President), Anthony Eisenberg (Chief Strategy Officer), Jason Chryssicas (Chief Financial Officer) and Ned Sizer (Chief Operating Officer) have resigned from their respective positions as officers of the Company
On October 2, 2023, Gregory A. Sigrist, Executive Vice President and Chief Financial Officer (“CFO”) of Metropolitan Holding Corp. (the “Company”), the holding company for Metropolitan Commercial Bank (the “Bank”), informed the Company that he intends to resign from his roles at the Company and the Bank, to be effective October 31, 2023
Jamere Jackson to the position of Chief Financial Officer
Mr. Brett Gross, CEO & President resigned from his position.
Effective as of October 15, 2023, the board of directors (the “Board”) of IR-Med, Inc. (the “Company”) appointed Mr. Tzur Di-Cori to serve as its Chief Executive Officer (CEO), effective October 15, 2023.
the Company has appointed Kari Keese to serve as Chief Financial Officer (Principal Financial and Accounting Officer) of the Company effective upon Mr. Dearen’s exit.
Dan L. Dearen, President and Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, will retire from the Company effective October 2, 2023
Riverview Bancorp, Inc. (“Company”) and its wholly-owned subsidiary, Riverview Bank (“Bank”), entered into a separation agreement and release (“Agreement”) with Kevin Lycklama, effective October 3, 2023, whose employment with the Company and the Bank as President and Chief Executive Officer ended effective September 6, 2023.
As previously announced, Carver Bancorp, Inc. (the “Company”) and Carver Federal Savings Bank (the “Bank”) appointed Craig C. MacKay (the “Executive”) as the Company’s and Bank’s Interim President and Chief Executive Officer, effective October 1, 2023.
Christopher Kirk, Ph.D., the Company’s co-founder and member of the Board, has been appointed to serve as Chief Executive Officer, effective as of the Effective Date.
On September 30, 2023, John Fowler, the Company’s co-founder, Chief Executive Officer and member of the Board, notified the Board that he will resign and cease serving as Chief Executive Officer, effective November 7, 2023
Scott Painter as Chief Executive Officer of EVe
Maximilian A. Staedtler as Chief Executive Officer of EVe
Curtis Pierce as Chief Financial Officer of EVe
Kash Sheikh as Chief Financial Officer of EVe
Effective on the Effective Date, J. Alexander Miller Douglas, the Company’s Chief Executive Officer, will assume the title Chief Executive Officer and President.
appointed Mr. Marcus Daley from Provo, UT as a Board of Director and Chief Executive Officer.
On October 2, 2023, Venugopal Rathi notified the Board of Directors (the “Board”) of T Series Middle Market Loan Fund LLC (the “Company”) of his resignation as the Company’s Chief Financial Officer in order to pursue other professional opportunities.
On October 2, 2023, the Board appointed Orit Mizrachi, the Company’s Chief Operating Officer, as interim Chief Financial Officer of the Company effective October 2, 2023.
On October 2, 2023, the Board appointed Orit Mizrachi, the Company’s Chief Operating Officer, as interim Chief Financial Officer of the Company effective October 2, 2023.
On October 2, 2023, Venugopal Rathi notified the Board of Directors (the “Board”) of North Haven Private Income Fund LLC (the “Company”) of his resignation as the Company’s Chief Financial Officer in order to pursue other professional opportunities.
On October 2, 2023, the Board appointed Orit Mizrachi, the Company’s Chief Operating Officer, as interim Chief Financial Officer of the Company effective October 2, 2023.
On October 2, 2023, Venugopal Rathi notified the Board of Directors (the “Board”) of North Haven Private Income Fund A LLC (the “Company”) of his resignation as the Company’s Chief Financial Officer in order to pursue other professional opportunities.
On October 2, 2023, Venugopal Rathi notified the Board of Directors (the “Board”) of SL Investment Corp. (the “Company”) of his resignation as the Company’s Chief Financial Officer in order to pursue other professional opportunities.
the Board appointed Orit Mizrachi, the Company’s Chief Operating Officer, as interim Chief Financial Officer of the Company effective October 2, 2023.
pursuant to which Mr. Akhavan will continue to serve as the President and Chief Executive Officer of EchoStar and will serve as a member of the Company Board upon the Effective Time
the DISH Board had approved the appointment of Mr. Hamid Akhavan as President and Chief Executive Officer of DISH and a member of the DISH Board, effective as of the date on which the Effective Time occurs
On October 2, 2023, the Company’s Board of Directors appointed Anthony D. Harnett to serve as Interim Chief Financial Officer of the Company, effective November 4, 2023.
On September 28, 2023, Mark A. Wilcox, Executive Vice President and Chief Financial Officer of Selective Insurance Group, Inc. (the “Company”), notified the Company that he has resigned from his position to pursue a different opportunity, effective November 3, 2023.
On September 29, 2023, Wayde McMillan, the Executive Vice President, Chief Financial Officer and Treasurer of Insulet Corporation (the “ Company ”) informed the Company of his decision to resign from such position, effective October 20, 2023.
The Company’s Chief Accounting Officer and Controller, Lauren Budden, 48, will serve as Interim Chief Financial Officer (“ CFO ”) and Treasurer, effective upon Mr. McMillan’s departure.
Colin Shannon has been appointed Chief Executive Officer of the Company, effective immediately.
Mr. Shannon succeeds Michelle Keefe, who will continue her tenure with the Company as a key member of the Executive Leadership Team.
On September 29, 2023, Baxter International Inc. (the “Company”) appointed Mr. Joel T. Grade as its Executive Vice President and Chief Financial Officer, effective as of October 18, 2023.
Ms. Molly S. Beerman, the Company’s current Executive Vice President and Chief Financial Officer, will continue in her roles as the Company’s Executive Vice President and Chief Financial Officer but will cease to serve as the Company’s principal accounting officer effective as of the Effective Date.
On October 1, 2023, Kiromic Biopharma, Inc. (the “Company”) entered into an executive employment agreement (the “Agreement”) with Brian Hungerford pursuant to which Mr. Hungerford will be employed by the Company as Chief Financial Officer.
On September 27, 2023, Kartoon Studios, Inc. (the “Company”) appointed Brian Parisi, age 53, as the Chief Financial Officer of the Company, effective September 27, 2023.
On October 2, 2023, the Company announced that, effective September 29, 2023, Ann P. Kelly’s employment was terminated as Executive Vice President and Chief Financial Officer.
On September 29, 2023, the Board of Directors of American Electric Power Company Inc. (“AEP” or “Company”) elected Charles E. Zebula to serve as AEP’s Executive Vice President and Chief Financial Officer effective as of September 30, 2023.
(b) As of September 29, 2023, Mr. Mark Bilancieri was appointed principal financial officer of the General Partner for purposes of the management of the Fund.
As of September 29, 2023, Mr. Christopher Guarnotta, acting as the principal financial officer of the General Partner for purposes of the management of the Fund, resigned from the General Partner.
Marc Lautenbach will step down from his position as President and Chief Executive Officer and as a member of the Board, effective as of the Transition Date.
the Board appointed Jason C. Dies, Executive Vice President and Group Executive of the Company, to the position of Interim Chief Executive Officer of the Company effective October 2, 2023
the Company and each of Howard Bernstein, Ph.D., Interim Chief Executive Officer of the Company, Richard Capasso, Chief Accounting Officer of the Company, Marshelle Smith Warren, M.D., Chief Medical Officer of the Company, and Lawrence Knopf, General Counsel of the Company (collectively, the “Executive Officers”) entered into a transition agreement amending the terms of the Executive Officer’s employment agreement with the Company. The transition agreements provide for an agreed employment termination date for the Executive Officers of November 15, 2023
Also on October 2, 2023, the Board of Directors appointed Amir Ayalon as the Company’s Chief Financial Officer.
On September 26, 2023, Bluejay Diagnostics, Inc. (the “Company”) and Kenneth R. Fisher agreed that Mr. Fisher would depart the Company as an employee and cease serving as its Chief Financial Officer (“CFO”).
On September 26, 2023, the Board of Directors (the “Board”) of the Company appointed Frances Scally, age 56, as interim CFO of the Company and designated her as the Company’s principal financial officer and principal accounting officer, effective immediately.
John Krier's resignation as Chief Executive Officer and as a member of its Board of Directors
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.